Donald McNicol
Pulmonary Disease · Norwalk, CTNPI 1912920034
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 107 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 22.7% — the pattern of someone who eats at a lot of different presentations.
Across 107 payments — averaging $16.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$405
- AstraZeneca$398
- Merck$241
- Biohaven Pharmaceutical Holding Company Ltd.$171
- Lilly USA, LLC$156
- Novo Nordisk$83
- plus $334 from 13 others
What the payments were for
- Food & beverage$1,788100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 28 | $405 |
| AstraZeneca | 25 | $398 |
| Merck | 12 | $241 |
| Biohaven Pharmaceutical Holding Company Ltd. | 10 | $171 |
| Lilly USA, LLC | 9 | $156 |
| Novo Nordisk | 4 | $83 |
| Otsuka America Pharmaceutical, Inc. | 4 | $66 |
| Pfizer | 2 | $34 |
| Amarin Pharma, Inc. | 2 | $34 |
| Eisai Inc. | 2 | $26 |
| Sanofi-aventis U.S. LLC | 1 | $25 |
| Almatica Pharma LLC | 1 | $23 |
| Johnson & Johnson | 1 | $22 |
| Amgen | 1 | $19 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $19 |
| Boehringer Ingelheim | 1 | $19 |
| Biohaven Pharmaceuticals, Inc. | 1 | $16 |
| Ultragenyx Pharmaceutical Inc. | 1 | $16 |
| GSK | 1 | $14 |
How this compares
$1,788 in reported general payments places this provider in the 55th percentile of 255 pulmonary disease providers in Connecticut.
Other pulmonary disease in Norwalk
- Geoffrey ChuppNew Haven$1.2M
- Tapas BandyopadhyayWest Hartford$483K
- Raj ParikhHartford$386K
- Patrick TroyHartford$385K
- Michael ImevboreNew Haven$323K
- Jeffrey NascimentoHartford$213K
- Thinesh DahanayakeNorwich$192K
- Naftali KaminskiNew Haven$180K
- Daniel GerardiHartford$156K
- Roman SpivakAnsonia$140K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.